CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $4.61B, above the global median of $1.18B
- FinancialsAltman Z-Score 7.15: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.40%Above 5Y avg (0.23%)
Annual Rate
KRW 2000.00Paid annual
Payout Ratio
11.7%Sustainable
Last Ex-Dividend
Mar 30, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
6.38TKRW4.61B · vs all stocks (USD)
Trailing P/E
37.62xRevenue (TTM)
1.66TKRW1.19B · vs all stocks (USD)
Profit Margin
13.11%Beta
0.5640xvs all stocks
52-Week Change
37.43%vs all stocks
Market Capitalization
6.38TKRW4.61B · vs all stocks (USD)
Enterprise Value
6.58TKRW4.75B · vs all stocks (USD)
Trailing P/E
37.62xForward P/E
28.14xPEG Ratio
0.3267xPrice to Sales (TTM)
3.86xPrice to Book (MRQ)
4.02xEnterprise to Revenue
3.97xEnterprise to EBITDA
17.50xGross Margin
64.89%Profit Margin
13.11%Operating Margin
26.43%Return on Assets (TTM)
8.04%Return on Equity (TTM)
16.36%Revenue (TTM)
1.66TKRW1.19B · vs all stocks (USD)
Revenue per Share (TTM)
130.52KKRWUpdated Sep 20, 2026Quarterly Revenue Growth
29.30%Gross Profit (TTM)
986.57BKRW712.11M · vs all stocks (USD)
EBITDA (TTM)
456.24BKRW329.31M · vs all stocks (USD)
Net Income (TTM)
217.04BKRW156.66M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
115.20%Operating Cash Flow (TTM)
272.90BKRW196.98M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
48.71BKRW35.16M · vs all stocks (USD)
Trailing Annual Dividend Rate
2.00KKRWUpdated Sep 20, 2026Trailing Annual Dividend Yield
0.40%vs all stocks
5-Year Average Dividend Yield
0.23%vs all stocks
Payout Ratio
11.70%Minority Interest (Equity)
173.10BKRWFY2025 · Dec 31, 2025Revenue
1.55TKRWFY2025 · Dec 31, 2025Cost of Goods Sold
663.12BKRWFY2025 · Dec 31, 2025Gross Profit
884.41BKRWFY2025 · Dec 31, 2025Operating Income
257.80BKRW186.08M · vs all stocks (USD)
Pre-tax Income
213.48BKRWFY2025 · Dec 31, 2025Income Tax Expense
26.34BKRWFY2025 · Dec 31, 2025Net Income
187.14BKRWFY2025 · Dec 31, 2025EBIT
230.46BKRWFY2025 · Dec 31, 2025EBITDA (Income Statement)
373.04BKRWFY2025 · Dec 31, 2025Research & Development
195.83BKRWFY2025 · Dec 31, 2025Selling, General & Administrative
225.89BKRWFY2025 · Dec 31, 2025Non-operating Interest Income
7.27BKRWFY2025 · Dec 31, 2025Non-operating Interest Expense
16.99BKRWFY2025 · Dec 31, 2025EPS (Basic)
13.37KKRWFY2025 · Dec 31, 2025EPS (Diluted)
13.36KKRWFY2025 · Dec 31, 2025Basic Shares Outstanding
12.68MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
12.68MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
187.14BKRWFY2025 · Dec 31, 2025Minority Interests (P&L)
-17.58BKRWFY2025 · Dec 31, 2025Operating Cash Flow
37.70BKRWFY2025 · Dec 31, 2025Free Cash Flow
-4.86BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
108.27BKRWFY2025 · Dec 31, 2025Starting Profit (CF Statement)
187.14BKRWFY2025 · Dec 31, 2025Other Non-cash Items
13.10BKRWFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-87.25BKRWFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-75.28BKRWFY2025 · Dec 31, 2025Capital Expenditures
-42.56BKRWFY2025 · Dec 31, 2025Net Intangibles (CF)
-33.00BKRWFY2025 · Dec 31, 2025Purchase of Investments
-113.41BKRWFY2025 · Dec 31, 2025Sale of Investments
59.78BKRWFY2025 · Dec 31, 2025Other Investing Activity
-3.97BKRWFY2025 · Dec 31, 2025Net Investing Cash Flow
-100.16BKRWFY2025 · Dec 31, 2025Long-term Debt Issuance
38.00BKRWFY2025 · Dec 31, 2025Long-term Debt Payments
-243.24BKRWFY2025 · Dec 31, 2025Net Short-term Debt Issuance
-81.84BKRWFY2025 · Dec 31, 2025Common Dividends Paid
-30.86BKRWFY2025 · Dec 31, 2025Net Financing Cash Flow
-317.93BKRWFY2025 · Dec 31, 2025Shares Outstanding
12.68MSharesUpdated Sep 20, 2026Float Shares
6.34MSharesUpdated Sep 20, 2026% Held by Insiders
50.12%vs all stocks
% Held by Institutions
21.91%vs all stocks
Total Cash (MRQ)
409.31BKRW295.44M · vs all stocks (USD)
Total Cash per Share (MRQ)
32.26KKRWUpdated Sep 20, 2026Total Debt (MRQ)
417.86BKRW301.61M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2630xCurrent Ratio (MRQ)
1.82xBook Value per Share (MRQ)
125.24KKRWUpdated Sep 20, 2026Total Assets
2.14TKRW1.54B · vs all stocks (USD)
Total Current Assets
893.95BKRWFY2025 · Dec 31, 2025Total Liabilities
714.74BKRWFY2025 · Dec 31, 2025Total Non-current Assets
1.24TKRWFY2025 · Dec 31, 2025Total Non-current Liabilities
109.54BKRWFY2025 · Dec 31, 2025Total Current Liabilities
605.20BKRWFY2025 · Dec 31, 2025Cash Equivalents
108.27BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents
108.27BKRWFY2025 · Dec 31, 2025Other Short-term Investments
93.05BKRWFY2025 · Dec 31, 2025Accounts Receivable
337.29BKRWFY2025 · Dec 31, 2025Inventory
338.53BKRWFY2025 · Dec 31, 2025Accounts Payable
54.25BKRWFY2025 · Dec 31, 2025Short-term Debt
337.49BKRWFY2025 · Dec 31, 2025Other Current Liabilities
-830.00KRWFY2025 · Dec 31, 2025Long-term Debt
96.73BKRWFY2025 · Dec 31, 2025Other Non-current Liabilities
-210.00KRWFY2025 · Dec 31, 2025Common Stock (Book)
32.03BKRWFY2025 · Dec 31, 2025Retained Earnings
836.49BKRWFY2025 · Dec 31, 2025Total Shareholders' Equity
1.42TKRW1.03B · vs all stocks (USD)
Treasury Stock
43.33BKRWFY2025 · Dec 31, 202552-Week Low
302.00KKRWUpdated Sep 20, 202652-Week High
647.00KKRWUpdated Sep 20, 202652-Week Change
37.43%vs all stocks
Beta
0.5640xvs all stocks
50-Day MA
423.60KKRWUpdated Sep 20, 2026200-Day MA
466.82KKRWUpdated Sep 20, 2026Avg 10-Day Volume
126.96KSharesUpdated Sep 20, 2026Avg 30-Day Volume
162.06KSharesUpdated Sep 20, 2026Diluted EPS (TTM)
13.36KKRWUpdated Sep 20, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 7.15: safe zoneNotable
Altman Z-Score: 7.15
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $4.61B, above the global median of $1.18BNotable
Market cap (USD): 4,606,977,160.859Global Median: 1,180,223,658.953
Revenue is $1.19B, above the global median of $548.88MNotable
Revenue (USD): 1,194,924,417.771Global Median: 548,883,780.48
Levered free cash flow is $35.16M, above the global median of $18.73MNotable
Levered free cash flow (USD): 35,160,253.231Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Mgi Tech Co Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Ajanta Pharma Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Humanwell Healthcare Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineFlowRule
Chongqing Zhifei Biological Products Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Suzhou Zelgen Biopharmaceuticals Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Simcere Pharmaceutical Group Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Henlius Biotech, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Haemonetics Corporation
Tier 1ProductionApproval-Gated PipelineRuleFlow
Sk Biopharmaceuticals Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Beijing Tong Ren Tang Co., Ltd.
Tier 1ProductionApproval-Gated PipelineFlowRule